1.
Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci. 2017;18(3):147-157. doi:10.1038/nrn.2016.183.
1.
Ahfeldt T, Litterman NK, Rubin LL. Studying human disease using human neurons. Brain Res. 2017;1656:40-48. doi:10.1016/j.brainres.2016.03.051.
1.
Chung W-S, Welsh CA, Barres BA, Stevens B. Do glia drive synaptic and cognitive impairment in disease?. Nat Neurosci. 2015;18(11):1539-1545. doi:10.1038/nn.4142.
1.
Therrien M, Heiman M. Resolving CNS mRNA Heterogeneity: Examining mRNA Alternative Polyadenylation at a Cell-Type-Specific Level. Neuron. 2017;95(6):1232-1233. doi:10.1016/j.neuron.2017.08.045.
1.
Abbott J, Ye T, Ham D, Park H. Optimizing Nanoelectrode Arrays for Scalable Intracellular Electrophysiology. Acc Chem Res. 2018;51(3):600-608. doi:10.1021/acs.accounts.7b00519.
1.
Watmuff B, Liu B, Karmacharya R. Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder. Pharmacogenomics. 2017;18(5):471-479. doi:10.2217/pgs-2016-0187.
1.
Ting JT, Daigle TL, Chen Q, Feng G. Acute brain slice methods for adult and aging animals: application of targeted patch clamp analysis and optogenetics. Methods Mol Biol. 2014;1183:221-42. doi:10.1007/978-1-4939-1096-0_14.
1.
Bilimoria PM, Stevens B. Microglia function during brain development: New insights from animal models. Brain Res. 2015;1617:7-17. doi:10.1016/j.brainres.2014.11.032.
1.
Mostafavi S, Gaiteri C, Sullivan SE, et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease. Nat Neurosci. 2018;21(6):811-819. doi:10.1038/s41593-018-0154-9.
1.
Aneichyk T, Hendriks WT, Yadav R, et al. Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly. Cell. 2018;172(5):897-909.e21. doi:10.1016/j.cell.2018.02.011.